Status:
COMPLETED
Marcaine Post-Operative Pain Study
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Effect of Drug
Eligibility:
All Genders
Up to 89 years
Phase:
EARLY_PHASE1
Brief Summary
The study examines the efficacy of Marcaine in post-operative pain reduction for patients receiving breast reduction surgery. Patients who consent will be randomized to which breast receives a Marcain...
Eligibility Criteria
Inclusion
- Must be receiving bilateral breast reduction surgery
Exclusion
- Unilateral breast reduction surgery
Key Trial Info
Start Date :
December 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04494880
Start Date
December 9 2020
End Date
December 31 2022
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Upstate University Hospital
Syracuse, New York, United States, 13210